Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004990159 | SCV005619263 | uncertain significance | Inborn genetic diseases | 2024-10-16 | criteria provided, single submitter | clinical testing | The c.5089A>C (p.M1697L) alteration is located in exon 35 (coding exon 35) of the LRRK2 gene. This alteration results from a A to C substitution at nucleotide position 5089, causing the methionine (M) at amino acid position 1697 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |